Penserra Capital Management LLC Zai Lab LTD Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$54.9 - $105.21 $87,016 - $166,757	-1,585 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $19,950 - $33,890	190 Added 13.62%	1,585 $167,000
Q2 2021 Aug 12, 2021	BUY	$125.11 - $180.0 $5,629 - $8,100	45 Added 3.33%	1,395 $246,000
Q1 2021 May 13, 2021	BUY	$126.27 - $191.71 $9,470 - $14,378	75 Added 5.88%	1,350 $180,000
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $65,961 - $108,948	805 Added 171.28%	1,275 $172,000
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $34,451 - $42,055	470 New	470 $39,000

116

40.8M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.02B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.